ArticlePloS one2024

An in silico investigation on the binding site preference of PD-1 and PD-L1 for designing antibodies for targeted cancer therapy.

Sarah Abdolmaleki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.